Chicago, November 28, 2018. This is an era of AI technology changing with each passing day. This is an era of innovators riding the wind and waves. At the RSNA venue in 2018, radiology experts from around the world appreciated the revolutionary wave from Chinese medical AI enterprises.

The annual conference on radiology in North America (RSNA), held in Windy City Chicago at the end of November every year, is an industry event with the largest scale, the largest number of participants and the most representative of the future technology trend and industry development direction in the world. Many revolutionary advances in radiology circles such as the world’s first CT, magnetic resonance and PET-CT are unveiled here to the world. For more than 100 years, RSNA has always led the technical trend and academic direction of the global radiology community.

China’s leading medical AI enterprise Yitu medical officially released the world’s first cancer screening intelligent diagnosis and treatment platform and care.aitm chest CT intelligent 4D imaging system based on medical artificial intelligence technology at the annual conference of radiology in North America (RSNA). This is the first time that Chinese medical AI enterprises released industrial solutions and the latest products at the same time on RSNA.

The intelligent diagnosis and treatment platform for cancer screening released this time relies on the advanced series of medical AI products of ETO medical, empowers the field of early cancer screening with artificial intelligence technology, and cooperates with hundreds of medical institutions in China to build an intelligent diagnosis and treatment platform covering lung cancer, breast cancer, cervical cancer, colorectal cancer and other high-risk cancers, providing AI services such as image detection, focus analysis, clinical decision-making assistance, patient management, etc. for clinical experts, This is the first serious disease screening based on a large sample population in the world by artificial intelligence technology.

As a powerful support of the intelligent diagnosis and treatment platform for cancer screening, care.aitm chest CT intelligent 4D imaging system breaks through the detection of single pulmonary nodule for the first time in the world. The lesion detection ability covers more than 95% of chest CT images such as nodule, patch shadow, strip shadow, cystic shadow, mediastinal lymph node and pleural effusion, and can complete the analysis and diagnosis of lesion signs and predict and evaluate the curative effect.

All AI products are amazing, and RSNA helps global tumor early screening

According to the 2018 global cancer annual report released by who, in 2018, it is estimated that there will be 18.1 million new cancer cases and 9.6 million cancer deaths worldwide. Lung cancer, breast cancer, colorectal cancer, prostate cancer, gastric cancer and other cancers are still growing rapidly. China is “listed” on the distribution map of many high-risk cancer species, and artificial intelligence technology is considered to be the most promising to improve the supply capacity of high-quality medical resources, Help large-scale early screening of cancer and effectively improve the five-year survival rate of high-risk cancer species.

However, as Vijay M. Rao, the president of this RSNA conference, MD said in an interview with daily bulletin: AI and machine learning applications have effectively proved their value in radiology. AI applications will liberate doctors from repetitive work and work more efficiently, but we only know the surface of these technologies.

For a long time, most of the lung imaging diagnostic products of medical AI enterprises focus on a single task of nodule detection, while nodules only account for 60% of all lesions seen in lung CT images, and the other patches, bands, cysts, etc., which account for about 40% of the total lesions, can not be detected, and mediastinal and pleural lesions closely related to the lung can not be detected.

Care.aitm chest CT intelligent 4D imaging system is a major breakthrough in the field of chest CT image intelligent diagnosis. It is the world’s first AI solution capable of all bit diagnosis. The system breaks through the detection of nodules for the first time in the industry. The detection ability of lesions covers more than 95% of chest CT images such as nodules, patch shadows, strip shadows, cystic shadows, mediastinal lymph nodes and pleural effusion, which is the first time in the world.

Based on the detection of lesions, the intelligent system makes a comprehensive quantitative intelligent analysis of these lesions. It can not only intelligently evaluate the malignant probability of lesions, but also provide the imaging basis of clinical staging for imaging diagnosis of malignant lesions. And through the original “yif elastic registration” technology, it can automatically register the images at any time point, endow the 3D images with accurate time dimension, deduce the important biological characteristics such as lesion doubling time, so as to provide rich information of more dimensions that human eyes can not observe and judge, and provide unprecedented AI intelligent diagnosis tools for radiologists.

Professor Jin Zhengyu, chairman of the radiology branch of the Chinese Medical Association and director of the radiology department of Peking Union Medical College Hospital, said at the release site: Medical AI that can only detect pulmonary nodules is not an assistant of radiologists. The release of care.aitm chest CT intelligent 4D imaging system is of great significance. The AI system that can cover a variety of lesions can effectively reduce the working pressure of clinicians, help early screening of tumors, change the medical AI from “available” to “easy to use”, and evolve to “necessary”.

In his speech at the meeting, Dr. Fang Yu, vice president of ETO medical, revealed that AI is becoming an important tool to help early cancer screening in China, and a large-scale tumor early screening action called “Ai cancer prevention map” has begun. Hundreds of medical institutions have been united, covering 19 provinces, cities and autonomous regions in China. AI application is used to improve the service supply capacity of medical institutions, help medical institutions carry out large-scale tumor early screening action, improve the tumor early screening level of regional residents, and provide reliable health data for large-scale clinical research.

From May to July 2018, 10 lung cancer patients were found in 1323 high-risk groups, including 9 cases of early lung cancer, in the AI early screening action of ETO medical and the Second Affiliated Hospital of Guangzhou Medical University, relying on the advanced low-dose spiral CT and lung cancer image intelligent diagnosis system. This is also the first time in the world to apply medical AI technology to the field of early tumor screening on a large scale.

Dr Fang said: “Medical AI products with advanced and reliable performance and meeting clinical needs are an important help for early screening of tumors, and China is making rapid progress in this field. ETO medical series AI products have been implemented in hundreds of top three hospitals in China, and the full coverage of county and municipal regional medical centers has been completed in some provinces. We look forward to bringing advanced AI products to all parts of the world and working together to promote the improvement of human medical and health care.”

Leave a Reply

Your email address will not be published.